These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 9491064)

  • 21. Tardive dyskinesia following risperidone treatment in Tourette's syndrome.
    Thomas N; Swamidhas P; Russell S; Angothu H
    Neurol India; 2009; 57(1):94-5. PubMed ID: 19305093
    [No Abstract]   [Full Text] [Related]  

  • 22. Tardive dyskinesia during treatment with risperidone.
    Haberfellner EM
    Pharmacopsychiatry; 1997 Nov; 30(6):271. PubMed ID: 9442551
    [No Abstract]   [Full Text] [Related]  

  • 23. Atypical presentation of tardive dyskinesia associated with risperidone long-acting injection as maintenance treatment in bipolar affective disorder: a case report.
    Chung AK
    Curr Drug Saf; 2012 Feb; 7(1):21-3. PubMed ID: 22663952
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Tardive dyskinesia from risperidone and olanzapine in an alcoholic man.
    Snoddgrass PL; Labbate LA
    Can J Psychiatry; 1999 Nov; 44(9):921. PubMed ID: 10584163
    [No Abstract]   [Full Text] [Related]  

  • 25. [Quetiapine treatment of risperidone-related tardive dyskinesia. A case report].
    Alcantara Lapaz AG; García Fernández L; Martínez MJ
    Actas Esp Psiquiatr; 2003; 31(5):306. PubMed ID: 14557956
    [No Abstract]   [Full Text] [Related]  

  • 26. Tardive dystonia induced by risperidone.
    Krebs MO; Olie JP
    Can J Psychiatry; 1999 Jun; 44(5):507-8. PubMed ID: 10389620
    [No Abstract]   [Full Text] [Related]  

  • 27. Withdrawal-emergent respiratory dyskinesia with risperidone treated with clozapine.
    Mendhekar DN; Inamdar A
    J Neuropsychiatry Clin Neurosci; 2010; 22(2):E24. PubMed ID: 20463136
    [No Abstract]   [Full Text] [Related]  

  • 28. New-onset tardive dyskinesia in patients with first-episode psychosis receiving risperidone or haloperidol.
    Gharabawi GM; Bossie CA; Zhu Y
    Am J Psychiatry; 2006 May; 163(5):938-9. PubMed ID: 16648343
    [No Abstract]   [Full Text] [Related]  

  • 29. Risperidone-induced tardive dyskinesia.
    Bassitt DP; de Souza Lobo Garcia L
    Pharmacopsychiatry; 2000 Jul; 33(4):155-6. PubMed ID: 10958268
    [No Abstract]   [Full Text] [Related]  

  • 30. Withdrawal-emergent dyskinesia in a patient on risperidone undergoing dosage reduction.
    Anand VS; Dewan MJ
    Ann Clin Psychiatry; 1996 Sep; 8(3):179-82. PubMed ID: 8899136
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Brief report: risperidone for severely disturbed behavior and tardive dyskinesia in developmentally disabled adults.
    Khan BU
    J Autism Dev Disord; 1997 Aug; 27(4):479-89. PubMed ID: 9261670
    [No Abstract]   [Full Text] [Related]  

  • 32. Risperidone treatment of tardive dyskinesia and dystonia.
    Chong SA; Remington G; Tan CH
    J Clin Psychiatry; 1999 May; 60(5):340-1. PubMed ID: 10362448
    [No Abstract]   [Full Text] [Related]  

  • 33. Long-term safety of risperidone.
    Davidson M
    J Clin Psychiatry; 2001; 62 Suppl 21():26-8. PubMed ID: 11584985
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Abnormal movements with the addition of clindamycin to risperidone in a girl with autism.
    Malone RP; Harvey JA
    J Child Adolesc Psychopharmacol; 2008 Apr; 18(2):221-2. PubMed ID: 18439121
    [No Abstract]   [Full Text] [Related]  

  • 35. The emerging role of atypical antipsychotics in the treatment of tardive dyskinesia induced by other atypical antipsychotics.
    Peritogiannis V; Tsouli S
    J Clin Psychiatry; 2011 Jul; 72(7):1016; author reply 1016-7. PubMed ID: 21824463
    [No Abstract]   [Full Text] [Related]  

  • 36. Rapid onset tardive dyskinesia ("fly catcher tongue") in a neuroleptically naive patient induced by risperidone.
    Friedman JH
    Med Health R I; 1998 Aug; 81(8):271-2. PubMed ID: 9727307
    [No Abstract]   [Full Text] [Related]  

  • 37. Attention deficit-hyperactivity disorder may be a risk factor for treatment-emergent tardive dyskinesia induced by risperidone.
    Silver H; Aharon N; Schwartz M
    J Clin Psychopharmacol; 2000 Feb; 20(1):112-4. PubMed ID: 10653224
    [No Abstract]   [Full Text] [Related]  

  • 38. Risperidone for severe tardive dyskinesia: a 12-week randomized, double-blind, placebo-controlled study.
    Bai YM; Yu SC; Lin CC
    J Clin Psychiatry; 2003 Nov; 64(11):1342-8. PubMed ID: 14658949
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Severe tardive dyskinesia during treatment with risperidone and fluoxetine].
    Dubbelman YD; Thung FH; Heeringa M
    Ned Tijdschr Geneeskd; 1998 Jun; 142(26):1508-11. PubMed ID: 9752071
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Atypical antipsychotic drugs and tardive dyskinesia: relevance of D2 receptor affinity.
    Bressan RA; Jones HM; Pilowsky LS
    J Psychopharmacol; 2004 Mar; 18(1):124-7. PubMed ID: 15107196
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.